Signet Financial Management’s AbbVie ABBV Stock Holding History

Signet Financial Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,500	Closed	-$4K	–	960
2018 Q2	$4K	Buy	+1,500	New	+$146K	﹤0.01%	735

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Signet Financial Management's ABBV Position: Q1 2026 in Review

Signet Financial Management reduced its AbbVie (ABBV) stake by 1.9% in Q1 2026, selling an estimated $108K and leaving 24,722 shares worth $5.38M. The position accounts for 0.6% of the portfolio, ranked #51.

Signet Financial Management first reported a position in ABBV in Q2 2015 and has held it in 42 quarters since. The position peaked at $9.28M in Q4 2017. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Signet Financial Management held 24,722 shares of AbbVie worth $5.38M as of Q1 2026.
Signet Financial Management sold 488 AbbVie shares in Q1 2026, an estimated $108K.
AbbVie made up 0.6% of Signet Financial Management's portfolio in Q1 2026, its #51 holding.
Signet Financial Management first reported a position in AbbVie in Q2 2015 and has held it in 42 quarters since.
Signet Financial Management's AbbVie position peaked at $9.28M in Q4 2017.
4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.